diphenyliodonium has been researched along with naloxone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SH; Chu, CH; Gao, H; Hong, JS; Wang, Q; Wilson, B; Zhou, H | 1 |
1 other study(ies) available for diphenyliodonium and naloxone
| Article | Year |
|---|---|
Naloxone inhibits immune cell function by suppressing superoxide production through a direct interaction with gp91phox subunit of NADPH oxidase.
Topics: Analysis of Variance; Animals; Biphenyl Compounds; Cell Membrane; Cells, Cultured; Chlorocebus aethiops; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Humans; Immunoprecipitation; Lipopolysaccharides; Membrane Glycoproteins; Mesencephalon; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidase 2; NADPH Oxidases; Naloxone; Neuroglia; Neurons; Neutrophils; Onium Compounds; Superoxide Dismutase; Superoxides; Tetradecanoylphorbol Acetate; Tetrazolium Salts; Thyroid Function Tests; Transfection; Tritium; Xanthine Oxidase | 2012 |